| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Melian Agustin is a Chief Medical Officer at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Medical Officer | Sell | 18,689 | $23.91 | $446,861.73 | -1.0% | -40.8% | -61.6% | |
| Sep 28, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Medical Officer | Sell | 3,750 | $24.12 | $90,432.38 | -0.8% | -45.6% | -66.4% | |
| Sep 17, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Medical Officer | Sell | 40,548 | $22.11 | $896,684.71 | -2.1% | -39.4% | -66.0% | |
| Mar 22, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Medical Officer | Sell | 3,750 | $25.97 | $97,393.50 | -0.7% | -16.2% | -68.2% | |
| Feb 2, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Medical Officer | Sell | 54,849 | $41.19 | $2,259,230.31 | -9.5% | - | - |